Spatial insights into immunotherapy response in non-small cell lung cancer (NSCLC) by multiplexed tissue imaging

被引:8
|
作者
Monkman, James [1 ]
Moradi, Afshin [1 ]
Yunis, Joseph [1 ,2 ]
Ivison, Geoff [3 ]
Mayer, Aaron [3 ]
Ladwa, Rahul [4 ]
O'Byrne, Ken [4 ]
Kulasinghe, Arutha [1 ]
机构
[1] Univ Queensland, Frazer Inst, Fac Med, 37 Kent St, Woolloongabba, Qld 4102, Australia
[2] Univ Queensland, Fac Med, Ian Frazer Ctr Childrens Immunotherapy Res, Childrens Hlth Res Ctr, Brisbane, Qld, Australia
[3] Enable Med, Menlo Pk, CA USA
[4] Princess Alexandra Hosp, Brisbane, Qld, Australia
关键词
IMMUNITY;
D O I
10.1186/s12967-024-05035-8
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The spatial localisation of immune cells within tumours are key to understand the intercellular communications that can dictate clinical outcomes. Here, we demonstrate an analysis pipeline for highly multiplexed CODEX data to phenotype and profile spatial features and interactions in NSCLC patients that subsequently received PD1 axis immunotherapy. We found that regulatory T cells (Tregs) are enriched in non-responding patients and this was consistent with their localization within stromal and peripheral tumour-margins. Proximity-based interactions between Tregs and both monocytes (p = 0.009) and CD8+ T cells (p = 0.009) were more frequently found in non-responding patients, while macrophages were more frequently located in proximity to HLADR+ tumour cells (p = 0.01) within responding patients. Cellular neighbourhoods analysis indicated that both macrophages (p = 0.003) and effector CD4+ T cells (p = 0.01) in mixed tumour neighbourhoods, as well as CD8+ T cells (p = 0.03) in HLADR+ tumour neighbourhoods were associated with favorable clinical response. Evaluation of the inferred regulatory functions between immune cells relative to the tumour suggested that macrophages exhibit an immunosuppressive phenotype against both CD4+ and CD8+ T cells, and that this association scores more highly in ICI refractory patients. These spatial patterns are associated with overall survival in addition to ICI response and may thus indicate features for the functional understanding of the tumour microenvironment.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Spatial insights into immunotherapy response in non-small cell lung cancer (NSCLC) by multiplexed tissue imaging
    James Monkman
    Afshin Moradi
    Joseph Yunis
    Geoff Ivison
    Aaron Mayer
    Rahul Ladwa
    Ken O’Byrne
    Arutha Kulasinghe
    Journal of Translational Medicine, 22
  • [2] DELINEATION OF SPATIAL TISSUE SIGNATURES OF IMMUNOTHERAPY RESPONSE GROUPS IN NON-SMALL CELL LUNG CANCER (NSCLC)
    Kulasinghe, Arutha
    Monkman, James
    Kim, Honesty
    Mayer, Aaron
    Mehdi, Ahmed
    Cumberbatch, Marie
    Bhagat, Milan
    Schneider, Fabian
    Thaagard, Jeppe
    Mansfield, James
    Ladwa, Rahul
    Mueller, Scott
    Adams, Mark
    O'byrne, Kenneth
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A130 - A130
  • [3] Immunotherapy for non-small cell lung cancer (NSCLC)
    Frost, Nikolaj
    Reck, Martin
    INNERE MEDIZIN, 2022, 63 (07): : 709 - 716
  • [4] Spatial profiling of non-small cell lung cancer provides insights into tumorigenesis and immunotherapy response
    Kim, Joon
    Yong, Seung Hyun
    Jang, Gyuho
    Kim, Yumin
    Park, Raekil
    Koh, Hyun-Hee
    Kim, Sehui
    Oh, Chang-Myung
    Lee, Sang Hoon
    COMMUNICATIONS BIOLOGY, 2024, 7 (01)
  • [5] Multi-omic and spatial dissection of immunotherapy response groups in non-small cell lung cancer (NSCLC).
    O'Byrne, Kenneth John
    Monkman, James
    Kim, Honesty
    Cumberbatch, Marie
    Bhagat, Milan
    Ladwa, Rahul
    Adams, Mark N.
    Kulasinghe, Arutha
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [6] Imaging of immunotherapy response in non-small cell lung cancer: challenges and perspectives
    Andrea Ciarmiello
    Rosa Fonti
    Giampiero Giovacchini
    Silvana Del Vecchio
    Clinical and Translational Imaging, 2018, 6 : 483 - 485
  • [7] Imaging of immunotherapy response in non-small cell lung cancer: challenges and perspectives
    Ciarmiello, Andrea
    Fonti, Rosa
    Giovacchini, Giampiero
    Del Vecchio, Silvana
    CLINICAL AND TRANSLATIONAL IMAGING, 2018, 6 (06) : 483 - 485
  • [8] Immunotherapy in previously treated non-small cell lung cancer (NSCLC)
    Leal, Ticiana A.
    Ramalingam, Suresh S.
    JOURNAL OF THORACIC DISEASE, 2018, 10 : S422 - S432
  • [9] Clinical Predictive Markers of Response to Immunotherapy in Advanced Non-Small Cell Lung Cancer (NSCLC)
    Rhone, R.
    Raez, L.
    Dumais, K.
    Powery, H.
    Gentile, F.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1083 - S1083
  • [10] Spatial omics and multiplexed imaging to discover new biomarkers of response or resistance to immune checkpoint inhibitors (ICI) in advanced non-small cell lung cancer (NSCLC)
    Moutafi, Myrto
    Martinez-Morilla, Sandra
    Garcia-Milian, Rolando
    Aung, Thazin Nwe
    Vathiotis, Ioannis
    Gavrielatou, Niki
    Xirou, Vasiliki
    Salichos, Leonidas
    Rimm, David L.
    CANCER RESEARCH, 2022, 82 (12)